MedPath

Effect of middle meningeal artery embolization for preventing recurrence of chronic subdural hematoma

Not Applicable
Recruiting
Conditions
Chronic subdural hematoma
Registration Number
JPRN-UMIN000028869
Lead Sponsor
ara Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with intracranial hypotension 2.Patients with contrast agent allergy 3.Patients who are difficult to treat catheters 4.Patients with advanced jaundice 5.Patients with advanced hypoalbuminemia 6.patients with thrombocytopenia 7.bleeding tendency patient 8.Patients with massive ascites 9.Patients with high grade hepatic encephalopathy 10,High renal function defect 11.pregnant women, patients in lactation 12.Others, patients judged by physicians as inappropriate as subjects of this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)recurrence within 12 weeks after the treatment 2)subdural space volume a day, 1,4,12 weeks after the treatment 3)neurological deficits
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath